Hill JS - Search Results

1

Phase I and pharmacokinetic study of photodynamic therapy for high-grade gliomas using a novel boronated porphyrin.

Rosenthal MA, Kavar B, Hill JS, Morgan DJ, Nation RL, Stylli SS, Basser RL, Uren S, Geldard H, Green MD, Kahl SB, Kaye AH. Rosenthal MA, et al. Among authors: hill js. J Clin Oncol. 2001 Jan 15;19(2):519-24. doi: 10.1200/JCO.2001.19.2.519. J Clin Oncol. 2001. PMID: 11208846 Clinical Trial.

2

Selective tumor uptake of a boronated porphyrin in an animal model of cerebral glioma.

Hill JS, Kahl SB, Kaye AH, Stylli SS, Koo MS, Gonzales MF, Vardaxis NJ, Johnson CI. Hill JS, et al. Proc Natl Acad Sci U S A. 1992 Mar 1;89(5):1785-9. doi: 10.1073/pnas.89.5.1785. Proc Natl Acad Sci U S A. 1992. PMID: 1542672 Free PMC article.

3

Selective tumor kill of cerebral glioma by photodynamic therapy using a boronated porphyrin photosensitizer.

Hill JS, Kahl SB, Stylli SS, Nakamura Y, Koo MS, Kaye AH. Hill JS, et al. Proc Natl Acad Sci U S A. 1995 Dec 19;92(26):12126-30. doi: 10.1073/pnas.92.26.12126. Proc Natl Acad Sci U S A. 1995. PMID: 8618857 Free PMC article.

4

Phase I and pharmacokinetic study of KRN8602 alone and with filgrastim in patients with advanced cancer.

Clarke K, Basser RL, Maher D, Morgan DJ, Cebon J, Fox RM, Hill JS, Alt C, Bartlett J, Geldard H, Kaye AH, Green MD. Clarke K, et al. Among authors: hill js. J Clin Oncol. 1998 Jun;16(6):2181-7. doi: 10.1200/JCO.1998.16.6.2181. J Clin Oncol. 1998. PMID: 9626219 Clinical Trial.

5

KRN8602 (MX2-hydrochloride): an active new agent for the treatment of recurrent high-grade glioma.

Clarke K, Basser RL, Underhill C, Mitchell P, Bartlett J, Cher L, Findlay M, Dalley D, Pell M, Byrne M, Geldard H, Hill JS, Maher D, Fox RM, Green MD, Kaye AH. Clarke K, et al. Among authors: hill js. J Clin Oncol. 1999 Aug;17(8):2579-84. doi: 10.1200/JCO.1999.17.8.2579. J Clin Oncol. 1999. PMID: 10561325 Clinical Trial.

6

Aluminium phthalocyanine mediated photodynamic therapy in experimental malignant glioma.

Stylli S, Hill J, Sawyer W, Kaye A. Stylli S, et al. J Clin Neurosci. 1995 Apr;2(2):146-51. doi: 10.1016/0967-5868(95)90008-x. J Clin Neurosci. 1995. PMID: 18638801

7

Evaluation of tumour and tissue distribution of porphyrins for use in photodynamic therapy.

Woodburn KW, Stylli S, Hill JS, Kaye AH, Reiss JA, Phillips DR. Woodburn KW, et al. Among authors: hill js. Br J Cancer. 1992 Mar;65(3):321-8. doi: 10.1038/bjc.1992.66. Br J Cancer. 1992. PMID: 1558783 Free PMC article.

8

Photodynamic therapy of brain tumors.

Popovic EA, Kaye AH, Hill JS. Popovic EA, et al. Among authors: hill js. Semin Surg Oncol. 1995 Sep-Oct;11(5):335-45. doi: 10.1002/ssu.2980110503. Semin Surg Oncol. 1995. PMID: 7569555 Review.

9

Photodynamic therapy.

Kaye AH, Hill JS. Kaye AH, et al. Among authors: hill js. J Neurosurg. 1994 Apr;80(4):774-5. doi: 10.3171/jns.1994.80.4.0774. J Neurosurg. 1994. PMID: 8151365 No abstract available.

10

Photodynamic therapy of brain tumours.

Kaye AH, Hill JS. Kaye AH, et al. Among authors: hill js. Ann Acad Med Singap. 1993 May;22(3 Suppl):470-81. Ann Acad Med Singap. 1993. PMID: 8215203 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

166 results

Search Page

Filters